AU2020311280B2 - Telmisartan for the treatment of chronic kidney disease in dogs - Google Patents

Telmisartan for the treatment of chronic kidney disease in dogs

Info

Publication number
AU2020311280B2
AU2020311280B2 AU2020311280A AU2020311280A AU2020311280B2 AU 2020311280 B2 AU2020311280 B2 AU 2020311280B2 AU 2020311280 A AU2020311280 A AU 2020311280A AU 2020311280 A AU2020311280 A AU 2020311280A AU 2020311280 B2 AU2020311280 B2 AU 2020311280B2
Authority
AU
Australia
Prior art keywords
telmisartan
dog
treatment
period
upc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020311280A
Other languages
English (en)
Other versions
AU2020311280A1 (en
Inventor
Scott Alan Brown
Kate Elizabeth Creevy
Amanda ERICKSON COLEMAN
Bianca Natália FERREIRA DE MOURA LOURENÇO
Anne Michelle Traas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
University of Georgia Research Foundation Inc
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
University of Georgia
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH, University of Georgia, University of Georgia Research Foundation Inc filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AU2020311280A1 publication Critical patent/AU2020311280A1/en
Application granted granted Critical
Publication of AU2020311280B2 publication Critical patent/AU2020311280B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2020311280A 2019-07-09 2020-04-30 Telmisartan for the treatment of chronic kidney disease in dogs Active AU2020311280B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962871752P 2019-07-09 2019-07-09
US62/871,752 2019-07-09
PCT/US2020/030579 WO2021006941A1 (en) 2019-07-09 2020-04-30 Telmisartan for the treatment of chronic kidney disease in dogs

Publications (2)

Publication Number Publication Date
AU2020311280A1 AU2020311280A1 (en) 2022-02-24
AU2020311280B2 true AU2020311280B2 (en) 2026-05-07

Family

ID=70775531

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020311280A Active AU2020311280B2 (en) 2019-07-09 2020-04-30 Telmisartan for the treatment of chronic kidney disease in dogs

Country Status (10)

Country Link
US (1) US20220218671A1 (enExample)
EP (1) EP3996705A1 (enExample)
JP (2) JP2022540074A (enExample)
KR (1) KR20220054291A (enExample)
CN (1) CN114450004A (enExample)
AU (1) AU2020311280B2 (enExample)
BR (1) BR112022000315A2 (enExample)
CA (1) CA3142876A1 (enExample)
MX (1) MX2022000429A (enExample)
WO (1) WO2021006941A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3996709A1 (en) 2019-07-09 2022-05-18 Boehringer Ingelheim Vetmedica GmbH Telmisartan for the treatment of hypertension in dogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ759782A (en) 2017-07-07 2023-06-30 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
A.C. BUGBEE, A.E. COLEMAN, A. WANG, A.D. WOOLCOCK, S.A. BROWN: "Telmisartan Treatment of Refractory Proteinuria in a Dog", JOURNAL OF VETERINARY INTERNAL MEDICINE, WILEY-BLACKWELL PUBLISHING, INC., US, vol. 28, no. 6, 1 November 2014 (2014-11-01), US, pages 1871 - 1874, XP055718581, ISSN: 0891-6640, DOI: 10.1111/jvim.12471 *
ALICIA CARO-VADILLO, MARIA ANGELES DAZA-GONZáLEZ, ELISA GONZALEZ-ALONSO-ALEGRE, ALFONSO RODRíGUEZ, JOSé GóMEZ-: "Effect of a combination of telmisartan and amlodipine in hypertensive dogs", VETERINARY RECORD CASE REPORTS, vol. 6, no. 2, 1 September 2018 (2018-09-01), pages e000471, XP055717977, DOI: 10.1136/vetreccr-2017-000471 *
BROWN SELLIOT JFRANCEY T ET AL.: "IRIS Canine GN Study Group Standard Therapy Subgroup, Consensus Recommendations for Standard Therapy of Glomerular Disease in Dogs", J VET INTERN MED, vol. 27, 2013, pages 27 - 43 *
H SCHIEROK, ET AL.: "Effects of Telmisartan on Renal Excretory Function in Conscious Dogs", THE JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1 January 2001 (2001-01-01), pages 131 - 139, XP055717982, Retrieved from the Internet <URL:https://journals.sagepub.com/doi/pdf/10.1177/147323000102900210> [retrieved on 20200724], DOI: 10.1177/147323000102900210 *
KONTA M.; NAGAKAWA M.; SAKATANI A.; AKABANE R.; MIYAGAWA Y.; TAKEMURA N.: "Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs", JOURNAL OF VETERINARY CARDIOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 20, no. 5, 17 August 2018 (2018-08-17), AMSTERDAM, NL, pages 376 - 383, XP085498223, ISSN: 1760-2734, DOI: 10.1016/j.jvc.2018.07.009 *
MARK J. ACIERNO, SCOTT BROWN, AMANDA E. COLEMAN, ROSANNE E. JEPSON, MARK PAPICH, REBECCA L. STEPIEN, HARRIET M. SYME: "ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats", JOURNAL OF VETERINARY INTERNAL MEDICINE, WILEY-BLACKWELL PUBLISHING, INC., US, vol. 32, no. 6, 1 November 2018 (2018-11-01), US, pages 1803 - 1822, XP055717957, ISSN: 0891-6640, DOI: 10.1111/jvim.15331 *
YONG-JIN KWON, SUH GUK-HYUN, KANG SEONG-SOO, KIM HA-JUNG: "Case Report Rapport de cas", 1 July 2018 (2018-07-01), pages 759 - 762, XP055717930, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005071/pdf/cvj_07_759.pdf> [retrieved on 20200724] *

Also Published As

Publication number Publication date
JP2025120167A (ja) 2025-08-15
BR112022000315A2 (pt) 2022-02-22
TW202116305A (zh) 2021-05-01
US20220218671A1 (en) 2022-07-14
KR20220054291A (ko) 2022-05-02
MX2022000429A (es) 2022-04-25
WO2021006941A1 (en) 2021-01-14
CN114450004A (zh) 2022-05-06
EP3996705A1 (en) 2022-05-18
AU2020311280A1 (en) 2022-02-24
JP2022540074A (ja) 2022-09-14
CA3142876A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
DK2420232T3 (en) Angiotensin-II receptor antagonist for the treatment of hypertension in cats
AU2026202684A1 (en) Telmisartan for the treatment of hypertension in dogs
JP2025120167A (ja) イヌの慢性腎臓病の治療のためのテルミサルタン
US10905676B2 (en) Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
WO2025125409A1 (en) Angiotensin ii receptor antagonist for the prevention of systemic diseases in cats
RU2832966C2 (ru) Телмисартан для лечения хронической болезни почек у собак
RU2830555C2 (ru) Телмисартан для лечения гипертонии у собак
JP2002523461A (ja) 神経変性疾患の治療方法
Torres Feline Chronic Kidney Disease
AU2007304216B9 (en) Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
AU2013203907B2 (en) Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CRICLEVIȚ et al. ON THE USE OF TRAZODONE IN VETERINARY MEDICINE